The Royal Society of Edinburgh (RSE) has relaunched its Enterprise Fellowship programme to help postdoctoral researchers turn academic research into commercial ventures, offering salary support, development funding and mentorship as it seeks to revive a scheme that has previously spawned hundreds of enterprises.
What the relaunch offers
The refreshed programme provides fellows with one year’s salary, access to a development fund of up to £10,000, and mentorship and peer-group support from RSE Fellows and former awardees. In addition, the new version of the fellowship can award a further £10,000 targeted specifically at international expansion.
- Salary support for 12 months to allow researchers to focus on commercialisation
- Development fund up to £10,000
- Additional up to £10,000 available for overseas growth
- Training, networking and mentorship from RSE Fellows and alumni
The relaunch is presented as a response to the changing needs of the research and business communities after a pause during the COVID-19 pandemic. The scheme will be administered by the RSE and is aimed at postdoctoral researchers based at UK higher education institutions who want to translate research into practical applications.
“The RSE Enterprise Fellowship Scheme has a brilliant track record of transforming research into real world application and turning ambition into business success,” said Mark Beaumont.
Track record and national significance
The fellowship originally ran from 1997 until 2021. Over that period it supported 272 Fellows drawn from 36 UK universities and helped create 166 businesses. Those outputs are concrete markers of how targeted support can convert research into companies — and, by implication, jobs and economic activity.
| Metric | Figure |
|---|---|
| Fellows supported (1997–2021) | 272 |
| Universities represented | 36 |
| Businesses created | 166 |
| Development fund (per fellow) | £10,000 (+ potential extra £10,000) |
For the national economy, the blend of salary support and modest development capital matters. One year of salary removes an immediate income barrier for researchers who might otherwise stay in academia or seek traditional employment, increasing the chance that a viable enterprise reaches the stage where it can hire staff, win contracts and raise private capital. The two-tier development funding — domestic plus a dedicated pot for international growth — signals an explicit ambition to scale ventures beyond the UK market.
What to watch
Past performance is a useful yardstick but not a guarantee. The RSE paused the scheme for a review during the pandemic to ensure it matched present-day needs — a prudent move, though it raises questions about how the relaunch will adapt to current economic headwinds such as higher borrowing costs, tighter investment budgets and skills shortages.
Key factors that will determine success include:
- Whether the funding envelope and mentorship translate into sustained revenue and hiring rather than short-term proof‑of‑concepts;
- How effectively the scheme helps fellows access follow‑on capital from investors or grant programmes; and
- The capacity of universities and regional ecosystems to support spin‑outs at scale, particularly outside major innovation hubs.
Professor Simon Best, who chairs the scheme, emphasised ambitions for global and social impact, and the RSE says the programme will draw on a wide network of Fellows to provide expertise. That human capital can be as valuable as the cash on offer, but mentorship alone does not create jobs or raise productivity unless matched by market traction.
For policymakers and business leaders focused on boosting productivity and high‑quality employment, the RSE relaunch is a pragmatic, low-cost instrument. If even a minority of fellows build firms that survive beyond the crucial first three years, the returns in terms of jobs, tax receipts and innovation diffusion could be substantial compared with the modest sums deployed.
The immediate test will be how many applications convert into commercially viable companies and whether the scheme leverages wider investment to move ventures from pilot stage to scale. For postdoctoral researchers weighing the leap from lab to market, the revived fellowship reduces personal financial risk — a small but meaningful tweak that could unlock discoveries into businesses.
